These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 29749763)

  • 1. Clonal evolution of Philadelphia chromosome in acute myeloid leukemia after azacitidine treatment.
    Yogarajah M; Montgomery N; Matson M; Blanchard L; Frank C; Gallagher S; Pepin K; Vaught L; Muluneh B; Foster MC; Zeidner JF
    Leuk Lymphoma; 2018 Dec; 59(12):3010-3012. PubMed ID: 29749763
    [No Abstract]   [Full Text] [Related]  

  • 2. Acquired BCR-ABL1 fusion and IDH1 clonal evolution following BCL2 inhibitor treatment in refractory acute myeloid leukemia.
    Adrianzen-Herrera D; Jordan-Bruno X; Devitt KA; Conant JL; Gardner JA
    Leuk Res; 2021 Jan; 100():106494. PubMed ID: 33387682
    [No Abstract]   [Full Text] [Related]  

  • 3. Decitabine studies in chronic and acute myelogenous leukemia.
    Kantarjian HM; O'Brien SM; Estey E; Giralt S; Beran M; Rios MB; Keating M; de Vos D; Talpaz M
    Leukemia; 1997 Mar; 11 Suppl 1():S35-6. PubMed ID: 9130691
    [No Abstract]   [Full Text] [Related]  

  • 4. Minor BCR-ABL1-Positive Acute Myeloid Leukemia Associated With the NPM1 Mutation and FLT3 Internal Tandem Duplication.
    Kim MJ; Ahn S; Jeong SH; Jang JH; Han JH; Choi JR; Cho SR
    Ann Lab Med; 2016 May; 36(3):263-5. PubMed ID: 26915617
    [No Abstract]   [Full Text] [Related]  

  • 5. Mutational analysis in serial marrow samples during azacitidine treatment in patients with post-transplant relapse of acute myeloid leukemia or myelodysplastic syndromes.
    Woo J; Howard NP; Storer BE; Fang M; Yeung CC; Scott BL; Deeg HJ
    Haematologica; 2017 Jun; 102(6):e216-e218. PubMed ID: 28209655
    [No Abstract]   [Full Text] [Related]  

  • 6. BCR-ABL1(+) acute myeloid leukemia: clonal selection of a BCR-ABL1(-) subclone as a cause of refractory disease with nilotinib treatment.
    Neuendorff NR; Schwarz M; Hemmati P; Türkmen S; Bommer C; Burmeister T; Dörken B; le Coutre P; Arnold R; Westermann J
    Acta Haematol; 2015; 133(2):237-41. PubMed ID: 25401297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of clonal evolution with Philadelphia chromosome in acute myeloid leukemia after hypomethylation agents and BCL2 inhibitor treatment.
    Kao SY; Hsiao SY; Du BH; Hsiao HH
    Kaohsiung J Med Sci; 2024 Oct; 40(10):947-948. PubMed ID: 39158166
    [No Abstract]   [Full Text] [Related]  

  • 8. A rare BCR-ABL1 transcript in Philadelphia-positive acute myeloid leukemia: case report and literature review.
    Piedimonte M; Ottone T; Alfonso V; Ferrari A; Conte E; Divona M; Bianchi MP; Ricciardi MR; Mirabilii S; Licchetta R; Campagna A; Cicconi L; Galassi G; Pelliccia S; Leporace A; Lo Coco F; Tafuri A
    BMC Cancer; 2019 Jan; 19(1):50. PubMed ID: 30630459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and phenotypic analysis of Philadelphia chromosome-positive bilineage leukemia: possibility of a lineage switch from T-lymphoid leukemic progenitor to myeloid cells.
    Monma F; Nishii K; Ezuki S; Miyazaki T; Yamamori S; Usui E; Sugimoto Y; Lorenzo V F; Katayama N; Shiku H
    Cancer Genet Cytogenet; 2006 Jan; 164(2):118-21. PubMed ID: 16434313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute myeloblastic leukemia.
    Molina CA; Rodríguez MJ; de Marcos NS; Font P
    Adv Ther; 2011 Mar; 28 Suppl 3():10-6. PubMed ID: 21431629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decitabine improves outcomes in older patients with acute myeloid leukemia and higher blast counts.
    Kadia TM; Thomas XG; Dmoszynska A; Wierzbowska A; Minden M; Arthur C; Delaunay J; Ravandi F; Kantarjian H
    Am J Hematol; 2015 Jul; 90(7):E139-41. PubMed ID: 25858582
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment with azacitidine for the simultaneous occurrence of multiple myeloma and acute myeloid leukemia with concomitant del(5q) and the JAK2 V617F mutation.
    Oka S; Ono K; Nohgawa M
    Ann Hematol; 2017 Aug; 96(8):1411-1413. PubMed ID: 28577044
    [No Abstract]   [Full Text] [Related]  

  • 13. Response and survival in acute myeloid leukemia patients not candidates to transplantation treated with azacitidine versus palliative treatment: a retrospective study.
    Sarmiento Maldonado M; Ocqueteau Tachini M; Pilcante J; Ramírez Villanueva P
    Medwave; 2015 Aug; 15(7):e6207. PubMed ID: 26335141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression analysis of decitabine treated AML: high impact of tumor suppressor gene expression changes.
    Bohl SR; Dolnik A; Jensen T; Lang KM; Hackanson B; Gaidzik VI; Paschka P; Knudsen S; Döhner K; Döhner H; Claus R; Lübbert M; Bullinger L
    Leuk Lymphoma; 2017 Sep; 58(9):1-4. PubMed ID: 28278722
    [No Abstract]   [Full Text] [Related]  

  • 15. Clonal evolution with double Ph followed by tetraploidy in imatinib-treated chronic myeloid leukemia with e19a2 transcript in transformation.
    Oshikawa G; Kurosu T; Arai A; Murakami N; Miura O
    Cancer Genet Cytogenet; 2010 May; 199(1):56-61. PubMed ID: 20417871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azacitidine for the treatment of patients with acute myeloid leukemia with 20%-30% blasts and multilineage dysplasia.
    Font P
    Adv Ther; 2011 Mar; 28 Suppl 3():1-9. PubMed ID: 21431628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case of azacitidine-induced maculopapular erythematous eruption.
    Ohashi A; Hayashi K; Okuyama R
    J Dermatol; 2013 Aug; 40(8):680-1. PubMed ID: 23734694
    [No Abstract]   [Full Text] [Related]  

  • 18. Azacitidine-induced Sweet syndrome: Two unusual clinical presentations.
    Tiwari SM; Caccetta T; Kumarasinghe SP; Harvey N
    Australas J Dermatol; 2018 Aug; 59(3):e224-e225. PubMed ID: 29044459
    [No Abstract]   [Full Text] [Related]  

  • 19. De novo acute myeloid leukemia with Philadelphia chromosome (BCR-ABL) and inversion 16 (CBFB-MYH11): report of two cases and review of the literature.
    Roth CG; Contis L; Gupta S; Agha M; Safyan E
    Leuk Lymphoma; 2011 Mar; 52(3):531-5. PubMed ID: 21281226
    [No Abstract]   [Full Text] [Related]  

  • 20. The clonal evolution of two distinct T315I-positive BCR-ABL1 subclones in a Philadelphia-positive acute lymphoblastic leukemia failing multiple lines of therapy: a case report.
    De Benedittis C; Papayannidis C; Venturi C; Abbenante MC; Paolini S; Parisi S; Sartor C; Cavo M; Martinelli G; Soverini S
    BMC Cancer; 2017 Aug; 17(1):523. PubMed ID: 28779753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.